Upward Trajectory: Virios Therapeutics Inc (VIRI) Posts a Slidee, Closing at 0.25

The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The closing price of Virios Therapeutics Inc (NASDAQ: VIRI) was $0.25 for the day, down -4.37% from the previous closing price of $0.26. In other words, the price has decreased by -$4.37 from its previous closing price. On the day, 1.6 million shares were traded. VIRI stock price reached its highest trading level at $0.2677 during the session, while it also had its lowest trading level at $0.2202.

Ratios:

Our analysis of VIRI’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.66 and its Current Ratio is at 5.66. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 21 ’23 when Pridgen William bought 15,335 shares for $1.30 per share. The transaction valued at 19,992 led to the insider holds 52,045 shares of the business.

Duncan Gregory Scott bought 25,000 shares of VIRI for $31,245 on Aug 17 ’23. The CHIEF EXECUTIVE OFFICER now owns 57,461 shares after completing the transaction at $1.25 per share.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VIRI now has a Market Capitalization of 6983887 and an Enterprise Value of 2465765.

Stock Price History:

The Beta on a monthly basis for VIRI is 1.62, which has changed by -0.8827907 over the last 52 weeks, in comparison to a change of 0.2086575 over the same period for the S&P500. Over the past 52 weeks, VIRI has reached a high of $2.20, while it has fallen to a 52-week low of $0.16. The 50-Day Moving Average of the stock is -3.49%, while the 200-Day Moving Average is calculated to be -46.93%.

Shares Statistics:

VIRI traded an average of 1.49M shares per day over the past three months and 2628480 shares per day over the past ten days. A total of 27.76M shares are outstanding, with a floating share count of 23.36M. Insiders hold about 15.84% of the company’s shares, while institutions hold 2.44% stake in the company. Shares short for VIRI as of 1719532800 were 312226 with a Short Ratio of 0.21, compared to 1717113600 on 335296. Therefore, it implies a Short% of Shares Outstanding of 312226 and a Short% of Float of 1.17.

Earnings Estimates

Current recommendations for the stock of the company come from 3.0 analysts. On average, analysts expect EPS of -$0.06 for the current quarter, with a high estimate of -$0.05 and a low estimate of -$0.07, while EPS last year was -$0.08. The consensus estimate for the next quarter is -$0.06, with high estimates of -$0.05 and low estimates of -$0.07.

Analysts are recommending an EPS of between -$0.22 and -$0.27 for the fiscal current year, implying an average EPS of -$0.25. EPS for the following year is -$0.19, with 3.0 analysts recommending between -$0.16 and -$0.21.

Most Popular